Minerva Neurosciences Statistics
Total Valuation
NERV has a market cap or net worth of $21.96 million. The enterprise value is -$12.96 million.
| Market Cap | 21.96M |
| Enterprise Value | -12.96M |
Important Dates
The next estimated earnings date is Tuesday, July 30, 2024, before market open.
| Earnings Date | Jul 30, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
NERV has 6.99 million shares outstanding. The number of shares has increased by 41.74% in one year.
| Shares Outstanding | 6.99M |
| Shares Change (YoY) | +41.74% |
| Shares Change (QoQ) | -0.15% |
| Owned by Insiders (%) | 22.26% |
| Owned by Institutions (%) | 30.32% |
| Float | 5.44M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 11.21 |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | n/a |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 12.58
| Current Ratio | 12.58 |
| Quick Ratio | n/a |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -53.20% |
| Return on Capital (ROIC) | n/a |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$3.51M |
| Employee Count | 9 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -66.13% in the last 52 weeks. The beta is 0.13, so NERV's price volatility has been lower than the market average.
| Beta (5Y) | 0.13 |
| 52-Week Price Change | -66.13% |
| 50-Day Moving Average | 2.98 |
| 200-Day Moving Average | 4.72 |
| Relative Strength Index (RSI) | 47.84 |
| Average Volume (20 Days) | 23,890 |
Short Selling Information
The latest short interest is 14,522, so 0.21% of the outstanding shares have been sold short.
| Short Interest | 14,522 |
| Short Previous Month | 15,354 |
| Short % of Shares Out | 0.21% |
| Short % of Float | 0.27% |
| Short Ratio (days to cover) | 0.21 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -24.45M |
| Pretax Income | -31.60M |
| Net Income | -31.60M |
| EBITDA | -31.57M |
| EBIT | -31.60M |
| Earnings Per Share (EPS) | -$4.48 |
Balance Sheet
The company has $34.92 million in cash and no debt, giving a net cash position of $34.92 million or $4.99 per share.
| Cash & Cash Equivalents | 34.92M |
| Total Debt | n/a |
| Net Cash | 34.92M |
| Net Cash Per Share | $4.99 |
| Equity (Book Value) | -36.59M |
| Book Value Per Share | -5.23 |
| Working Capital | 32.79M |
Cash Flow
| Operating Cash Flow | -20.76M |
| Capital Expenditures | n/a |
| Free Cash Flow | -20.76M |
| FCF Per Share | -$2.74 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
NERV does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -41.74% |
| Shareholder Yield | -41.74% |
| Earnings Yield | -143.92% |
| FCF Yield | -94.55% |
Analyst Forecast
The average price target for NERV is $7.00, which is 122.93% higher than the current price. The consensus rating is "Hold".
| Price Target | $7.00 |
| Price Target Difference | 122.93% |
| Analyst Consensus | Hold |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on June 21, 2022. It was a reverse split with a ratio of 1:8.
| Last Split Date | Jun 21, 2022 |
| Split Type | Reverse |
| Split Ratio | 1:8 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |